Desogestrel/Ethinylestradiol Adalvo

Medicinal product

(Invented) name

Desogestrel/Ethinylestradiol Adalvo

Active substance (s)

Dezogestrelis/Etinilestradiolis

Strength

150 µg/20 µg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G03AA09, Desogestrel and ethinylestradiol

Marketing authorisation holder

AdAlvo Limited, Malta

Date of authorisation

2024-12-20

Date of renewal

Documents

5657_pakuotes lapelis_2025-09-30.docx

5657_Desog_Ethin_Adalvo_PAR_SD+Summ+LT.pdf

5657_Desoges_Ethynil_Adalvo_2025-09-30.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

LT/H/0217/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Dezogestrelis	150 µg
Etinilestradiolis	20 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116049	102150	1102150	lizdinė plokštelė	N1×21		Receptinis	LT/1/24/5657/001	Netiekiama	-	-	No	-	-
116050	102151	1102151	lizdinė plokštelė	N3×21		Receptinis	LT/1/24/5657/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-12-20	Registruotas